oxidopamine has been researched along with Nervous System Disorders in 10 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shah, A | 1 |
| Garzon-Muvdi, T | 1 |
| Mahajan, R | 1 |
| Duenas, VJ | 1 |
| Quiñones-Hinojosa, A | 1 |
| Chao, OY | 1 |
| Pum, ME | 1 |
| Li, JS | 1 |
| Huston, JP | 1 |
| Aubin, N | 1 |
| Barneoud, P | 1 |
| Carter, C | 1 |
| Caille, D | 1 |
| Sontag, N | 1 |
| Marc, C | 1 |
| Lolivier, J | 1 |
| Gardes, A | 1 |
| Perron, C | 1 |
| Le Kim, A | 1 |
| Charieras, T | 1 |
| Pandini, M | 1 |
| Burnier, P | 1 |
| Puech, F | 1 |
| Jegham, S | 1 |
| George, P | 1 |
| Scatton, B | 1 |
| Curet, O | 1 |
| Seiden, LS | 1 |
| Vosmer, G | 1 |
| Jonsson, G | 1 |
| Gorio, A | 1 |
| Hallman, H | 1 |
| Janigro, D | 1 |
| Kojima, H | 1 |
| Luthman, J | 1 |
| Zanoni, R | 1 |
| Matias, A | 1 |
| Soares-da-Silva, P | 1 |
| Azevedo, I | 1 |
| Steiner, JP | 1 |
| Hamilton, GS | 1 |
| Ross, DT | 1 |
| Valentine, HL | 1 |
| Guo, H | 1 |
| Connolly, MA | 1 |
| Liang, S | 1 |
| Ramsey, C | 1 |
| Li, JH | 1 |
| Huang, W | 1 |
| Howorth, P | 1 |
| Soni, R | 1 |
| Fuller, M | 1 |
| Sauer, H | 1 |
| Nowotnik, AC | 1 |
| Suzdak, PD | 1 |
| Strömberg, I | 1 |
| Bickford-Wimer, P | 1 |
| Naudin, B | 1 |
| Saligaut, C | 1 |
| Costentin, J | 1 |
| Schmidt, CJ | 1 |
| Black, CK | 1 |
| Taylor, VL | 1 |
1 review available for oxidopamine and Nervous System Disorders
| Article | Year |
|---|---|
Animal models of neurological disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Amyloid beta-Protein Precursor; Ani | 2010 |
9 other studies available for oxidopamine and Nervous System Disorders
| Article | Year |
|---|---|
The grid-walking test: assessment of sensorimotor deficits after moderate or severe dopamine depletion by 6-hydroxydopamine lesions in the dorsal striatum and medial forebrain bundle.
Topics: Amphetamine; Animals; Antiparkinson Agents; Behavior, Animal; Corpus Striatum; Dopamine; Dopamine Up | 2012 |
SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzophenones; Brain; Corpus Striatum; Disease Models, Anim | 2004 |
Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Hydroxydopamines; Male; Methamph | 1984 |
Effects of GM1 ganglioside on developing and mature serotonin and noradrenaline neurons lesioned by selective neurotoxins.
Topics: 5,7-Dihydroxytryptamine; Animals; Animals, Newborn; Female; G(M1) Ganglioside; Gangliosides; Hydroxy | 1984 |
Neurotoxicity and induction of fibroblast proliferation by acetaldehyde in the rabbit liver.
Topics: Acetaldehyde; Animals; Cell Division; Fibroblasts; Liver; Nervous System Diseases; Norepinephrine; O | 1993 |
Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Carrier Proteins; Cells, Cultured; Chickens; | 1997 |
Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Caudate Nucleus; C | 1991 |
Influence of oxygen availability on the neurotoxic effect of 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atmospheric Pressure; Chromatography, High Pressure Liquid; | 1991 |
Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; | 1990 |